MIMIX Sustained Release

The MIMIX microneedle patch is the only system capable of sustaining delivery of vaccines and immunotherapies in the skin. MIMIX is placed on the skin for only five minutes, yet the system continues to deliver the active ingredient for anywhere from days to weeks.

The MIMIX platform dramatically improves efficacy of vaccines and immunotherapies by “mimicking” the prolonged exposure period that occurs during a natural infection. In addition, the patch improves the patient experience through the elimination of the needle and syringe while also incorporating Vaxess’s high temperature stability to allow for simple shipping and storage.

A Simple 5-Minute MIMIX Application Delivers Product Into the Skin For Weeks

MIMIX utilizes the versatility of silk fibroin as a building block for next generation biomaterials.
By tuning the structural and functional properties of silk fibroin constructs, Vaxess can engineer delivery profiles to precisely match the optimal release kinetics.

We envision a class of therapeutic and vaccine products that combine innovations in both form and function to deliver robust, effective healthcare to patients worldwide.